# Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy

> **NCT06150729** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 107 (actual)

## Conditions studied

- Spasticity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06150729
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-08
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06150729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06150729, "Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06150729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*